Hidroxicloroquina/Cloroquina

A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19-32173110.pdf

Antimalarials for the treatment of COVID-19-Systematic Review-Epistemonikos.pdf

Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State-32392282.pdf

Chloroquine and hydroxychloroquine as available weapons to fight COVID-19-32145363.pdf

Chloroquine in COVID19 The Evidence- 32231349.pdf

Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies-32074550.pdf

COVID-19 outbreak and surgical practice: unexpected fatality interioperative period-32221117

Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection-.32330277

Efficacy of hydroxychloroquine in patients with COVID-19_results of a randomized clinical trial-[preprint].pdf

Emerging prophylaxis strategies against COVID-19-32231348.pdf

Excitement around hydroxychloroquine for treating COVID-19 causes challenges for rheumatology-News-Lancet

Hydroxychloroquine and azithromycin as a treatment of COVID-19results of an open-label non-randomized clinical trial-32205204.pdf

Hydroxychloroquine for COVID-19: what’s the evidence?- Commentary-Medscape

Hydroxychloroquine or Chloroquine for COVID-19_ Drug Safety Communication – FDA Cautions Against Use Outside of the Hospital Setting or a Clinical Trial Due to Risk of Heart Rhythm Problems _ FDA.pdf

Informative note on the current evidence of the efficacy and safety of hydroxychloroquine and azithromycin as a preventative treatment for COVID-19-Nota informativa sobre l’evidència actual de l’eficàcia i seguretat de la hidrNota informativa sobre l’evidència actual de l’eficàcia i seguretat de la hidroxicloroquina i l’azitromicina com a tractament o prevenció de la COVID-19-Información para profesionales-Servei Català de la Salut

Is hydroxychloroquine a possible post-exposure prophylaxis drug to limit the transmission to health care workers exposed to COVID19-32211764

Is there a future for hydroxychloroquine/chloroquine in prevention of SARS-CoV-2 infection (COVID-19)?_32317315.pdf

No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 Infection-32240719

Observational Study of Hydroxychloroquinein Hospitalized Patients with Covid-19-32379955 .pdf

Of chloroquine and COVID-19-32147496.pdf

Outcomes of hydroxychloroquine usage in United States veterans hospitalized with Covid-19-[pre-print].pdf

Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)-32356863.pdf

Safety signals for QT prolongation or Torsades de Pointes associated with azithromycin with or without chloroquine or hydroxychloroquine-32327397.pdf

The trial of chloroquine in the treatment of corona virus disease 2019 (COVID-19) and its research progress in forensic toxicology-[chino]-32212513

Virological and Clinical Cure in Covid-19 Patients Treated With Hydroxychloroquine A Systematic Review and Meta-Analysis-32297988.pdf

¿Cuál es la eficacia de la hidroxicloroquina en el tratamiento de la COVID-19?-Clinical trial-Cochrane Iberoamérica .pdf